CBUS.NASDAQCibus, INC

Form 4: Cibus Inc. Director Gerhard Prante Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Gerhard Prante sold 1,150 shares of Cibus, Inc. stock at $2.35 per share on February 20, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • On February 20, 2025, Gerhard Prante, a director of Cibus, Inc., sold 1,150 shares of Class A Common Stock.
  • The sale was executed at a price of $2.35 per share.
  • The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 16, 2024.
  • Following the sale, Prante directly owns 11,157 shares of Cibus, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by insiders are a common occurrence and are closely watched by investors for signals about a company's prospects. A pre-arranged 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on non-public information.

Stakeholder Impact

  • The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

DateDescription
08/16/2024Date of adoption of Rule 10b5-1 trading plan
02/20/2025Date of transaction (stock sale)
02/21/2025Date of signature on Form 4

Keywords

Form 4, Cibus Inc., Gerhard Prante, Director, Stock Sale, Rule 10b5-1, Class A Common Stock, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.